Artificial intelligence (AI) is transforming healthcare by enabling faster, more accurate analysis of complex biological and clinical data. It supports drug development, guides personalized treatment choices and speeds up research discoveries. By integrating diverse datasets and creating predictive models, AI boosts efficiency, improves outcomes and promotes innovation across medicine, diagnostics and genomic research.
The report includes:
- Analysis of the impact of artificial intelligence on global gene fusion testing market
- Case studies for successful integration of AI in gene fusion testing market
- The analyst's viewpoint on how AI and automation is redefining the market landscape for gene fusion testing
- Highlights of AI adoption trends across the major geographical regions as well as disruptions caused by AI across key industry verticals
- Review of AI impact on the various stages of the global supply chain
- Competitive intelligence featuring key strategic initiatives, market spendings and an investment outlook
Table of Contents
Chapter 1 Key Use Cases for AI Adoption in Gene Fusion Testing- Overview
- Key Use Cases/Case Studies
- Case 1: Pharmaceutical and Biotechnology Companies
- Case 2: Hospitals and Diagnostic Laboratories
- Case 3: Academic and Research Centers
- Adoption Trends by Region
- Adoption Trends in North America
- Adoption Trends in Europe
- Adoption Trends in Asia-Pacific
- Adoption Trends in the Rest of the World
- Impact of AI on Key Industry Verticals
- Pharmaceutical and Biotechnology Companies
- Hospitals and Diagnostic Laboratories
- Academic and Research Centers
- Impact of AI on Various Stages of the Supply Chain
- Sample Collection and Processing
- Conducting Testing
- Data Analysis and Interpretation
- Clinical Decision Support
- Overview
- Market Spending and Forecasting Analysis
- Key Spending by Gene Fusion Testing Companies on AI
- Venture Capital Investment in AI for Gene Fusion Testing
- Notable VC Investments
- Abbreviations Used in the Report
Table 1: Key Initiatives by Companies on AI, 2024-2025
Table 2: Key Spending by Companies on AI-based Gene Fusion Testing, 2024-2025
Table 3: Abbreviations Used in This Report
List of Figures
Figure 1: Impact of AI on Value Chain
